FS

Palliative Care Symptom Management: Constipation, Nausea/Vomiting, Anorexia/Cachexia, Fatigue

Constipation in Palliative Care

  • Definition and scope
    • In palliative care, constipation is defined as a difficult passage of hard or infrequent stools with a change in normal pattern, typically a bowel movement every <3\text{ days}, often with straining or pain.
    • The goal is a comfortable bowel movement, generally aiming for every <3\text{ days} rather than a fixed stool form.
  • Why constipation happens in this setting
    • Very common and multifactorial; opioids (including strong opioids and tramadol) contribute to constipation.
    • Contributing factors in frail patients include loss of independence, lack of privacy when passing stools, and caregiver-patient dynamics that disrupt regular bowel routines.
    • Disease-related factors: hypercalcemia (metabolic), malignant spinal cord compression leading to reduced mobility and bowel propulsion.
  • History and assessment
    • Ask about cramps, bloating, nausea, flatulence to identify underlying contributors.
    • Don’t omit the rectal exam; it helps identify stool burden, impaction, or potential higher bowel obstruction.
  • Laxatives and treatment approach
    • Use combinations of laxatives with different mechanisms to enhance bowel movement.
    • Bulk-forming/laxatives that require lots of water are often impractical in palliative patients due to nausea, poor appetite, and limited hydration; avoid relying on them when feasible.
    • Prevention is better than cure; consider prophylactic laxatives to avoid painful episodes later.
  • The Five F’s ( mnemonic for common constipation causes )
    • Five F’s provide an easy recall for common etiologies in patients with advancing disease (the transcript mentions the mnemonic but does not enumerate the five terms).
  • Psychosocial considerations and functional impact
    • Caregivers: privacy, independence, and potential embarrassment when needing to pass stool or be cleaned up.
    • Some patients may only attempt a bowel movement when a specific nurse is on duty, which is unsafe and compromises quality of life.
  • Underlying causes, interventions, and the care plan
    • Distinguish underlying, potentially reversible causes from symptom-directed interventions.
    • The goal is to prevent constipation and ensure a comfortable bowel movement.
  • Bowel obstruction: partial vs complete; anatomical site; mechanical vs physiological
    • Mechanical obstruction often presents as partial or complete depending on the blockage; partial obstructions may respond to propulsive laxatives, while complete obstructions usually require escalation.
    • Anatomical site (small bowel vs large bowel) influences management decisions.
    • Propulsive laxatives may be used in partial obstruction (low burden). Example discussed: \text{methadrylproamide} (propulsive approach).
    • Complete obstruction: if relief is not possible surgically or with a stent, stoma creation (colostomy or gastrostomy) may be considered.
  • Rectal exam and monitoring
    • A rectal exam is essential to assess for impaction or obstruction and should not be skipped.
  • Goals of constipation management
    • Prevent constipation where possible; once it occurs, aim for a comfortable bowel movement every <3\text{ days}.
  • Practical considerations for caregivers
    • Coordinating care to maintain hygiene and dignity; balancing caregiver workload with patient comfort.
  • Additional notes
    • Bowel management is integrated with cancer care; consider interactions with other medications and overall symptom burden.

Nausea and Vomiting in Palliative Care

  • Definitions and prevalence
    • Nausea: unpleasant feeling of the need to vomit; Vomiting: forceful expulsion of gastric contents.
    • Approximately 50\% of patients with advanced cancer experience nausea and vomiting.
  • Pathways and pathophysiology
    • Vomiting center in the brainstem integrates multiple pathways:
    • Cortical stimuli (pain, fear, anxiety, smells, memories)
    • Vestibular system (motion sickness, balance disorders)
    • Vagal afferent signals from upper GI tract
    • Chemoreceptor trigger zone (CTZ) in the brain
  • Common causes to consider
    • Bowel obstruction, gastritis or gastric stasis, constipation, ascites causing early satiety, excessive coughing with reflex retching.
  • Goals of treatment
    • Address underlying reversible causes where possible.
    • If not reversible, have discussions with patient/family about tolerable goals (e.g., one morning vomit but acceptable symptom control the rest of the day).
  • Routes and pharmacologic considerations
    • Route of antiemetic can be tailored for home care; subcutaneous injections for family administration and sublingual ondansetron for rapid absorption bypassing the GI tract.
    • Understanding pathways guides choice of antiemetic (CTZ-targeting, vestibular, or gastric motility agents).
  • Practical management
    • Consider the patient’s preferences and daily functioning when selecting antiemetics.
    • Mouth care, hydration strategies, and small frequent meals can help alongside medications.
  • Special considerations
    • Distinguish nausea vs vomiting to target the most bothersome symptoms for the patient.

Anorexia and Cachexia

  • Definitions and clinical significance
    • Anorexia: reduction in desire to eat and drink, leading to reduced oral intake.
    • Cachexia: involuntary loss of more than >10\% of pre-morbid body weight due to metabolic abnormalities that cannot be fully reversed by nutrition alone.
  • Pathophysiology and contributors
    • Chronic inflammatory state drives a catabolic process affecting muscle and fat; metabolic abnormalities are not fully reversed by caloric supplementation.
    • Treatment-related factors such as chemotherapy altering taste (foods may taste like cardboard); dysphagia; mucositis; depression; sleep disturbance; dyspnea.
  • Clinical implications for patients and families
    • Weight loss and appetite changes are significant concerns; patients and families may worry about prognosis and quality of life.
    • In advanced disease, appetite naturally declines and activity reduces, reinforcing a cycle of reduced intake.
  • Nutritional goals at end of life
    • Do not force weight gain or aggressive nutrition; the focus is on comfort, meaning, and manageable intake.
    • Hydration and nutrition decisions should balance burden versus potential benefit for the patient.
  • Diet, supplements, and practical feeding strategies
    • Diet: offer nutrient-dense foods in small volumes; emphasize foods with high caloric density (e.g., peanut butter, eggs) and avoid high-volume meals when ascites or obstruction is present.
    • Supplements: used to reduce the volume of food needed rather than to drive weight gain; prioritise foods with high calories per unit volume.
  • Appetite stimulants and medical options
    • Pharmacologic appetite stimulants include steroids, progestogens, and cannabinoids.
  • Psychological and social considerations
    • Feeding is often a culturally important way of showing care; patients may feel pressured or judged when not eating; caregivers need guidance and support.
    • Ethical debates around continuing or withdrawing nutrition/hydration at end of life; decisions should balance patient preferences, medical benefit, and caregiver burden.
  • Practical tips
    • Mouth care and taste alterations matter; consider palliative flavor enhancers or preferred textures.
    • Emphasise comfort and enjoyability of meals; avoid pressuring patients to eat more than they can.

Fatigue in Palliative Care

  • Causes and multifactorial nature
    • Fatigue is very common due to sarcopenia, dyspnea, anemia, pain, depression, insomnia, and overall illness burden.
  • Management principles
    • Identify and address reversible contributors; adopt a multi-factorial approach; prioritize non-pharmacological strategies first.
    • Energy budgeting: establish a daily energy allowance and plan activities around it.
  • Non-pharmacological strategies
    • Gentle activity and regular, yet limited, physical therapy; passive movements; energy-conserving activities; scheduling meaningful tasks when energy is highest.
  • Pharmacologic options
    • Steroids can temporarily boost energy.
    • Methylphenidate (Ritalin) can provide short-term energy for planned events (e.g., a family celebration).
    • Short-term stimulant use is considered for specific goals and patient preference.
  • Practical recommendations
    • Encourage small, manageable activities; avoid overexertion; adapt daily routines to energy levels; involve family to support activities.

Ethical, Communicative, and Empowerment Considerations

  • Core philosophy
    • Quality of life is what the patient says it is; pain is subjective; constipation and other symptoms must be understood from the patient’s perspective.
  • Approach to care
    • Adopt a multi-problem, multi-factorial approach; prioritize prevention and early management; educate and empower patients and families to participate in care.
  • End-of-life nutrition and hydration discussions
    • There is ongoing ethical debate about continuing nutrition and IV hydration in actively dying patients; decisions should balance burden, benefit, and patient values.
  • Communication strategies
    • Open, honest conversations about goals and expectations; involve patient and family in decision-making; provide practical support (mouth care, comfort measures) to preserve dignity.

Practical Takeaways for Clinical Practice

  • Prevention first: prevent constipation, manage nausea, support nutrition and energy, and implement early supportive care.
  • Do not overlook the rectal exam; it informs whether stool impaction or obstruction is present.
  • Constipation management: use a combination of laxatives with different mechanisms; avoid relying solely on bulk-forming laxatives when hydration/comfort limits apply.
  • Nausea and vomiting: distinguish between nausea and vomiting; tailor antiemetic therapy to the likely pathway; prefer non-oral routes when vomiting is frequent.
  • Anorexia/cachexia: prioritize comfort and meaningful intake; use calorie-dense foods and small portions; avoid pressuring weight gain; consider appetite stimulants only if aligned with patient goals.
  • Fatigue: address reversible factors; implement energy budgeting and meaningful activities; consider short-term stimulant therapy for critical events.
  • Communication and ethics: continually engage patients and families; educate and empower; address the emotional and cultural context of feeding and hydration at end of life.
  • Final message: the goal is relief of suffering, preservation of dignity, and patient-centered care through clear communication and collaborative decision-making.